tiprankstipranks
Trending News
More News >
Astrana Health (ASTH)
NASDAQ:ASTH
US Market

Astrana Health (ASTH) Earnings Dates, Call Summary & Reports

Compare
226 Followers

Earnings Data

Report Date
Jul 31, 2025
TBA Not Confirmed
Period Ending
2025 (Q2)
Consensus EPS Forecast
0.35
Last Year’s EPS
0.4
Same Quarter Last Year
Based on 11 Analysts Ratings
---

Earnings Call Summary

Earnings Call Date:May 08, 2025
|
% Change Since: -20.16%
|
Next Earnings Date:Jul 31, 2025
Earnings Call Sentiment|Positive
Astrana Health's first quarter results demonstrate strong revenue growth and effective expansion strategies, particularly in the Care Partners segment and emerging markets. The company is successfully integrating acquisitions and preparing for future growth with favorable Medicare Advantage rates. However, challenges with medical cost trends, margin pressures, and potential regulatory impacts present risks that need to be managed. Overall, the positive aspects slightly outweigh the challenges.
Company Guidance
During the Astrana Health First Quarter 2025 Earnings Call, the company provided robust guidance and insights into its financial and operational performance. Astrana reported total revenue of $620.4 million, a 53% increase year-over-year, with a significant contribution from the Care Partners segment, which grew 57% to $600 million. The company achieved an adjusted EBITDA of $36.4 million, driven by organic growth and strategic acquisitions, including CHS, which contributed $95 million. Membership expanded to 910,000, with 38% now in full-risk contracts, accounting for 75% of capitated revenue. Astrana projects full-year revenue of $2.5 to $2.7 billion and adjusted EBITDA of $170 to $190 million. The company expects revenue between $615 million and $665 million and adjusted EBITDA of $45 million to $50 million for the second quarter. Furthermore, Astrana remains confident in its medium-term goal of at least $350 million in adjusted EBITDA by 2027, supported by continued strategic acquisitions and enhancements in its AI-enabled technology infrastructure.
Significant Revenue Growth
Astrana Health reported a total revenue of $620.4 million, representing a 53% increase compared to the prior year period.
Strong Performance of Care Partners Segment
The Care Partners segment grew by 57% year over year to $600 million, driving the company's revenue growth.
Expansion in Emerging Markets
In Nevada and Texas, Astrana Health achieved significant growth and operational execution, with Nevada reaching breakeven and membership in the risk-bearing network growing by 40%.
Increased Membership in Full-Risk Arrangements
Approximately 38% of members are now in full-risk contracts, up from 5.5% a year ago, accounting for 75% of capitated revenue.
Successful CHS Integration
CHS integration is complete with over $10 million in G&A efficiencies identified, and performance in line with expectations.
Upcoming Prospect Health Acquisition
The planned acquisition of Prospect Health is expected to significantly expand the provider network and contribute $81 million in adjusted EBITDA with $12 million to $15 million in synergies.
Positive Medicare Advantage Rate Notice
The 2026 Medicare Advantage rate notice is favorable and expected to support continued growth and profitability.
---

Astrana Health (ASTH) Earnings, Revenues Date & History

The upcoming earnings date is based on a company’s previous reporting, and may be updated when the actual date is announced

ASTH Earnings History

Report Date
Fiscal Quarter
Forecast / EPS
Last Year's EPS
EPS YoY Change
Press Release
Slides
Play Transcript
Jul 31, 2025
2025 (Q2)
0.34 / -
0.4
May 08, 2025
2025 (Q1)
0.21 / 0.14
0.31-54.84% (-0.17)
Feb 27, 2025
2024 (Q4)
0.10 / -0.15
0.26-157.69% (-0.41)
Nov 07, 2024
2024 (Q3)
0.31 / 0.33
0.47-29.79% (-0.14)
Aug 07, 2024
2024 (Q2)
0.39 / 0.40
0.2842.86% (+0.12)
May 07, 2024
2024 (Q1)
0.30 / 0.31
0.310.00% (0.00)
Feb 27, 2024
2023 (Q4)
0.15 / 0.26
-0.06533.33% (+0.32)
Nov 07, 2023
2023 (Q3)
0.33 / 0.47
0.56-16.07% (-0.09)
Aug 07, 2023
2023 (Q2)
0.25 / 0.28
0.2512.00% (+0.03)
May 08, 2023
2023 (Q1)
0.31 / 0.31
0.310.00% (0.00)
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
---

ASTH Earnings-Related Price Changes

Report Date
Price 1 Day Before
Price 1 Day After
Percentage Change
May 08, 2025
$33.44$29.71-11.15%
Feb 27, 2025
$34.68$25.38-26.82%
Nov 07, 2024
$59.08$46.96-20.51%
Aug 07, 2024
$46.36$46.85+1.06%
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
---

FAQ

When does Astrana Health (ASTH) report earnings?
Astrana Health (ASTH) is schdueled to report earning on Jul 31, 2025, TBA Not Confirmed.
    What is Astrana Health (ASTH) earnings time?
    Astrana Health (ASTH) earnings time is at Jul 31, 2025, TBA Not Confirmed.
      Where can I see when companies are reporting earnings?
      You can see which companies are reporting today on our designated earnings calendar.
        What companies are reporting earnings today?
        You can see a list of the companies which are reporting today on TipRanks earnings calendar.
          What is ASTH EPS forecast?
          ASTH EPS forecast for the fiscal quarter 2025 (Q2) is 0.35.
            ---
            What am I Missing?
            Make informed decisions based on Top Analysts' activity
            Know what industry insiders are buying
            Get actionable alerts from top Wall Street Analysts
            Find out before anyone else which stock is going to shoot up
            Get powerful stock screeners & detailed portfolio analysis